Kintara Therapeutics, Inc. reported earnings results for the full year ended June 30, 2023. For the full year, the company reported net loss was USD 14.65 million compared to USD 22.66 million a year ago. Basic loss per share from continuing operations was USD 9.27 compared to USD 25.8 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1488 USD | -5.82% | +22.57% | -12.26% |
Apr. 03 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Apr. 03 | Sector Update: Health Care | MT |
1st Jan change | Capi. | |
---|---|---|
-12.26% | 8.23M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- KTRA Stock
- News Kintara Therapeutics, Inc.
- Kintara Therapeutics, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023